When all Else Fails, Try This: The HeartMate III Left Ventricle Assist Device.
Cardiol Clin
; 41(4): 593-602, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37743081
ABSTRACT
Heart failure (HF) is a progressive disease. It is estimated that more than 250,000 patients suffer from advanced HF with reduced ejection fraction refractory to medical therapy. With limited donor pool for heart transplant, continue flow left ventricle assist device (LVAD) is a lifesaving treatment option for patients with advanced HF. This review will provide an update on indications, contraindications, and associated adverse events for LVAD support with a summary of the current outcomes data.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heart-Assist Devices
/
Heart Transplantation
/
Heart Failure
Limits:
Humans
Language:
En
Journal:
Cardiol Clin
Year:
2023
Document type:
Article